Allscripts (MDRX) Tops Q2 EPS by 6c

Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.23, $0.06 better than the analyst estimate of $0.17. Revenue for the quarter came in at $374 million versus the consensus estimate of $373.45 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Wall Street's new pair trade: Long software, short chips
• Morgan Stanley Downgrades Stellantis NV (STLA:FP) (STLA) to Underweight
• BofA sees just 2% upside for the S&P 500 over the next 12 months